Table 1.
Brain region | Outcome | Effect | LogWorth | p value | R 2 |
---|---|---|---|---|---|
| |||||
Hippocampus | CASI-IRT | Ihc at8 | 2.59 | 0.0026 | 0.30 |
Ihc Aβ ffpe | 2.50 | 0.0031 | |||
mem | Aβ42/Aβ40 ratio | 2.52 | 0.0031 | 0.22 | |
ihc at8 | 0.85 | 0.1420 | |||
exf | ihc tau2 ffpe | 4.15 | < 0.0001 | 0.32 | |
Il-1β pg/mg | 2.04 | 0.0091 | |||
lan | ihc at8 ffpe | 3.91 | 0.0001 | 0.55 | |
ihc iba1 ffpe | 2.82 | 0.0015 | |||
vsp | mcp1 pg/mg | 2.99 | 0.0010 | 0.62 | |
ihc gfap ffpe | 2.82 | 0.0015 | |||
TCx | CASI-IRT | tE/I ratio | 2.28 | 0.0052 | 0.15 |
Aβ1–42 pg/mg | 1.36 | 0.0438 | |||
mem | ihc Aβ | 1.17 | 0.0675 | 0.09 | |
tE/I ratio | 0.79 | 0.1618 | |||
exf | tE/I ratio | 1.96 | 0.0111 | 0.10 | |
mip1a pg/mg | 0.55 | 0.2797 | |||
lan | ihc at8 ffpe | 4.57 | < 0.0001 | 0.39 | |
Ihc gfap ffpe | 2.56 | 0.0027 | |||
vsp | ihc at8 | 1.61 | 0.0248 | 0.21 | |
Aβ1–40 pg/mg | 1.56 | 0.0275 | |||
PCx | CASI-IRT | tE/I ratio | 4.21 | < 0.0001 | 0.46 |
Isoprostane pg/mg | 2.92 | 0.0012 | |||
mem | tE/I ratio | 3.65 | 0.00022 | 0.43 | |
ihc Aβ | 2.90 | 0.0013 | |||
exf | ihc Aβ ffpe | 5.87 | < 0.00001 | 0.70 | |
tE/I ratio | 5.77 | < 0.00001 | |||
lan | ihc Aβ | 5.39 | < 0.00001 | 0.51 | |
ihc α-syn | 4.00 | 0.0001 | |||
vsp | Aβ42 pg/mg | 3.62 | 0.0002 | 0.39 | |
ihc Aβ | 3.34 | 0.0005 |
Outcome, Y variable; CASI-IRT, cognitive scores from the Cognitive Abilities Screening Instrument using Item Response Theory; mem, exf, lan, vsp, normalized metrics for memory, executive function, language, and visual spatial performance, respectively; Effect, X variable; LogWorth, – log10(p value). R2, variation explained by the model; TCx, temporal cortex; PCx parietal cortex. Ihc Z, % of area covered by Z immunoreactivity on fresh tissue; Ihc Z ffpe, % of area covered by Z immunoreactivity on formalin-fixed, parafilm-embedded tissue. AT8, monoclonal antibody recognizing tau protein phosphorylated at ser202 and thr205; Tau2 reacts with 52–68 kDa tau in phosphorylated and non-phosphorylated forms; Il 1b pg/mg, interleukin 1b; ibai, ionized calcium-binding adaptor molecule; mcpl pg/mg, monocyte chemoattractant protein-1; gfap, glial fibrillary acidic protein; Aβ1–42 pg/mg, 42 amino-acid beta-amyloid peptide derived from the amyloid precursor protein (APP); mip1a pg/mg, macrophage inflammatory protein-1 alpha; Aβ1–40 pg/mg, 40-amino acid beta-amyloid peptide derived from APP; Isoprostane pg/mg, prostaglandin-like compounds produced by the reaction of free radicals with arachidonic acid; α-syn, α-synuclein. Bold letters highlight the cases where tE/I ratio effects were significant. See data for all effects in Supplementary dataset 18 (online resource)